Immunogenomic Classification of Colorectal Cancer and Therapeutic Implications
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Immunogenomic Classification of Colorectal Cancer and Therapeutic Implications
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 18, Issue 10, Pages 2229
Publisher
MDPI AG
Online
2017-10-24
DOI
10.3390/ijms18102229
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Genomic characterization of liver metastases from colorectal cancer patients
- (2017) J.M. Sayagués et al. EUROPEAN JOURNAL OF CANCER
- Identification of genetic determinants of breast cancer immune phenotypes by integrative genome-scale analysis
- (2017) Wouter Hendrickx et al. OncoImmunology
- Conservation of immune gene signatures in solid tumors and prognostic implications
- (2016) Julia Chifman et al. BMC CANCER
- The State of Immune Checkpoint Inhibition in Urothelial Carcinoma
- (2016) Matthew T. Campbell et al. CANCER JOURNAL
- Accumulation of MDSC and Th17 Cells in Patients with Metastatic Colorectal Cancer Predicts the Efficacy of a FOLFOX–Bevacizumab Drug Treatment Regimen
- (2016) Emeric Limagne et al. CANCER RESEARCH
- STK11/LKB1 Deficiency Promotes Neutrophil Recruitment and Proinflammatory Cytokine Production to Suppress T-cell Activity in the Lung Tumor Microenvironment
- (2016) S. Koyama et al. CANCER RESEARCH
- HDAC Inhibitors Enhance T-Cell Chemokine Expression and Augment Response to PD-1 Immunotherapy in Lung Adenocarcinoma
- (2016) Hong Zheng et al. CLINICAL CANCER RESEARCH
- Immune and Stromal Classification of Colorectal Cancer Is Associated with Molecular Subtypes and Relevant for Precision Immunotherapy
- (2016) Etienne Becht et al. CLINICAL CANCER RESEARCH
- Disentangling the relationship between tumor genetic programs and immune responsiveness
- (2016) Davide Bedognetti et al. CURRENT OPINION IN IMMUNOLOGY
- HLA-G and classical HLA class I expression in primary colorectal cancer and associated liver metastases
- (2016) Marloes Swets et al. HUMAN IMMUNOLOGY
- MAP Kinase Inhibition Promotes T Cell and Anti-tumor Activity in Combination with PD-L1 Checkpoint Blockade
- (2016) Peter J.R. Ebert et al. IMMUNITY
- Integrative Analyses of Colorectal Cancer Show Immunoscore Is a Stronger Predictor of Patient Survival Than Microsatellite Instability
- (2016) Bernhard Mlecnik et al. IMMUNITY
- Immunogenic Chemotherapy Sensitizes Tumors to Checkpoint Blockade Therapy
- (2016) Christina Pfirschke et al. IMMUNITY
- Immunoscore and Immunoprofiling in cancer: an update from the melanoma and immunotherapy bridge 2015
- (2016) J. Galon et al. Journal of Translational Medicine
- Predictive biomarkers for checkpoint inhibitor-based immunotherapy
- (2016) Geoffrey T Gibney et al. LANCET ONCOLOGY
- Mutations of KRAS/NRAS/BRAF predict cetuximab resistance in metastatic colorectal cancer patients
- (2016) Hung-Chih Hsu et al. Oncotarget
- Immunoscore encompassing CD3+ and CD8+ T cell densities in distant metastasis is a robust prognostic marker for advanced colorectal cancer
- (2016) Yoonjin Kwak et al. Oncotarget
- Immune-Derived PD-L1 Gene Expression Defines a Subgroup of Stage II/III Colorectal Cancer Patients with Favorable Prognosis Who May Be Harmed by Adjuvant Chemotherapy
- (2016) P. D. Dunne et al. Cancer Immunology Research
- Immunogenic Subtypes of Breast Cancer Delineated by Gene Classifiers of Immune Responsiveness
- (2016) L. D. Miller et al. Cancer Immunology Research
- Leukocytes recruited by tumor-derived HMGB1 sustain peritoneal carcinomatosis
- (2016) Lucia Cottone et al. OncoImmunology
- Patterns of metastasis in colon and rectal cancer
- (2016) Matias Riihimäki et al. Scientific Reports
- Immune-modulating properties of ionizing radiation: rationale for the treatment of cancer by combination radiotherapy and immune checkpoint inhibitors
- (2015) Anja Derer et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Phase I/II study of adjuvant immunotherapy with sentinel lymph node T lymphocytes in patients with colorectal cancer
- (2015) Yun-Huan Zhen et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Comparative analysis of primary tumour and matched metastases in colorectal cancer patients: Evaluation of concordance between genomic and transcriptional profiles
- (2015) Stéphane Vignot et al. EUROPEAN JOURNAL OF CANCER
- Integrative Genomic and Transcriptomic Characterization of Matched Primary and Metastatic Liver and Colorectal Carcinoma
- (2015) Stephanie Roessler et al. International Journal of Biological Sciences
- Nivolumab for Metastatic Renal Cell Carcinoma: Results of a Randomized Phase II Trial
- (2015) Robert J. Motzer et al. JOURNAL OF CLINICAL ONCOLOGY
- Upregulation of PD-L1 by EGFR Activation Mediates the Immune Escape in EGFR-Driven NSCLC: Implication for Optional Immune Targeted Therapy for NSCLC Patients with EGFR Mutation
- (2015) Nan Chen et al. Journal of Thoracic Oncology
- Myeloid-Derived Suppressor Cells and Therapeutic Strategies in Cancer
- (2015) Hiroshi Katoh et al. MEDIATORS OF INFLAMMATION
- Melanoma-intrinsic β-catenin signalling prevents anti-tumour immunity
- (2015) Stefani Spranger et al. NATURE
- Stromal gene expression defines poor-prognosis subtypes in colorectal cancer
- (2015) Alexandre Calon et al. NATURE GENETICS
- The consensus molecular subtypes of colorectal cancer
- (2015) Justin Guinney et al. NATURE MEDICINE
- Robust enumeration of cell subsets from tissue expression profiles
- (2015) Aaron M Newman et al. NATURE METHODS
- PD-1 Blockade in Tumors with Mismatch-Repair Deficiency
- (2015) Dung T. Le et al. NEW ENGLAND JOURNAL OF MEDICINE
- The Microsatellite Instable Subset of Colorectal Cancer Is a Particularly Good Candidate for Checkpoint Blockade Immunotherapy
- (2015) Yanping Xiao et al. Cancer Discovery
- An integrative approach for the identification of prognostic and predictive biomarkers in rectal cancer
- (2015) Marco Agostini et al. Oncotarget
- Characterization of the immunophenotypes and antigenomes of colorectal cancers reveals distinct tumor escape mechanisms and novel targets for immunotherapy
- (2015) Mihaela Angelova et al. GENOME BIOLOGY
- Novel cancer antigens for personalized immunotherapies: latest evidence and clinical potential
- (2015) Gregory T. Wurz et al. Therapeutic Advances in Medical Oncology
- Tumor-intrinsic oncogene pathways mediating immune avoidance
- (2015) Stefani Spranger et al. OncoImmunology
- Combined immune checkpoint protein blockade and low dose whole body irradiation as immunotherapy for myeloma
- (2015) Weiqing Jing et al. Journal for ImmunoTherapy of Cancer
- Targeting the TGFβ pathway with galunisertib, a TGFβRI SMI, promotes anti-tumor immunity leading to durable, complete responses, as monotherapy and in combination with checkpoint inhibition
- (2015) David Schaer et al. Journal for ImmunoTherapy of Cancer
- Adverse Immunoregulatory Effects of 5FU and CPT11 Chemotherapy on Myeloid-Derived Suppressor Cells and Colorectal Cancer Outcomes
- (2014) J. Kanterman et al. CANCER RESEARCH
- Occurrence of Tertiary Lymphoid Tissue Is Associated with T-Cell Infiltration and Predicts Better Prognosis in Early-Stage Colorectal Cancers
- (2014) G. Di Caro et al. CLINICAL CANCER RESEARCH
- 5-Fluorouracil causes leukocytes attraction in the peritoneal cavity by activating autophagy and HMGB1 release in colon carcinoma cells
- (2014) Lucia Cottone et al. INTERNATIONAL JOURNAL OF CANCER
- The effect of immune microenvironment on the progression and prognosis of colorectal cancer
- (2014) Jinxiang Chen et al. MEDICAL ONCOLOGY
- Tertiary lymphoid structures in cancer and beyond
- (2014) Marie-Caroline Dieu-Nosjean et al. TRENDS IN IMMUNOLOGY
- Characterization of an adaptive immune response in microsatellite-instable colorectal cancer
- (2014) Florence Boissière-Michot et al. OncoImmunology
- HMGB1 recruits myeloid derived suppressor cells to promote peritoneal dissemination of colon cancer after resection
- (2013) Wei Li et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- IRF-1 responsiveness to IFN-γ predicts different cancer immune phenotypes
- (2013) D Murtas et al. BRITISH JOURNAL OF CANCER
- Combined analysis of HLA class I, HLA-E and HLA-G predicts prognosis in colon cancer patients
- (2013) E C M Zeestraten et al. BRITISH JOURNAL OF CANCER
- CXCR3/CCR5 pathways in metastatic melanoma patients treated with adoptive therapy and interleukin-2
- (2013) D Bedognetti et al. BRITISH JOURNAL OF CANCER
- Cancer-associated fibroblast and M2 macrophage markers together predict outcome in colorectal cancer patients
- (2013) Mercedes Herrera et al. CANCER SCIENCE
- Characteristics and Clinical Impacts of the Immune Environments in Colorectal and Renal Cell Carcinoma Lung Metastases: Influence of Tumor Origin
- (2013) R. Remark et al. CLINICAL CANCER RESEARCH
- CTLA-4 and PD-1/PD-L1 Blockade: New Immunotherapeutic Modalities with Durable Clinical Benefit in Melanoma Patients
- (2013) P. A. Ott et al. CLINICAL CANCER RESEARCH
- The Gastrointestinal Tumor Microenvironment
- (2013) Michael Quante et al. GASTROENTEROLOGY
- Implementation of tumor testing for lynch syndrome in endometrial cancers at a large academic medical center
- (2013) Jessica Moline et al. GYNECOLOGIC ONCOLOGY
- The Continuum of Cancer Immunosurveillance: Prognostic, Predictive, and Mechanistic Signatures
- (2013) Jérôme Galon et al. IMMUNITY
- Spatiotemporal Dynamics of Intratumoral Immune Cells Reveal the Immune Landscape in Human Cancer
- (2013) Gabriela Bindea et al. IMMUNITY
- Characteristics and significance of colorectal cancer associated lymphoid reaction
- (2013) Juha P. Väyrynen et al. INTERNATIONAL JOURNAL OF CANCER
- Prediction of Response to Anticancer Immunotherapy Using Gene Signatures
- (2013) Ena Wang et al. JOURNAL OF CLINICAL ONCOLOGY
- Combining Radiotherapy and Cancer Immunotherapy: A Paradigm Shift
- (2013) Silvia C. Formenti et al. JNCI-Journal of the National Cancer Institute
- Mechanism of MEK inhibition determines efficacy in mutant KRAS- versus BRAF-driven cancers
- (2013) Georgia Hatzivassiliou et al. NATURE
- Interactions between immunity, proliferation and molecular subtype in breast cancer prognosis
- (2013) Srikanth Nagalla et al. GENOME BIOLOGY
- Hepatic metastases of colorectal cancer are rather homogeneous but differ from primary lesions in terms of immune cell infiltration
- (2013) Niels Halama et al. OncoImmunology
- Mutually exclusive redox forms of HMGB1 promote cell recruitment or proinflammatory cytokine release
- (2012) Emilie Venereau et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Cancer classification using the Immunoscore: a worldwide task force
- (2012) Jérôme Galon et al. Journal of Translational Medicine
- The Distribution of Macrophages with a M1 or M2 Phenotype in Relation to Prognosis and the Molecular Characteristics of Colorectal Cancer
- (2012) Sofia Edin et al. PLoS One
- IL-17 is associated with poor prognosis and promotes angiogenesis via stimulating VEGF production of cancer cells in colorectal carcinoma
- (2011) Jiankun Liu et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Localization and Density of Immune Cells in the Invasive Margin of Human Colorectal Cancer Liver Metastases Are Prognostic for Response to Chemotherapy
- (2011) N. Halama et al. CANCER RESEARCH
- Immunotherapeutic modulation of the suppressive liver and tumor microenvironments
- (2011) Tim Chan et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- The seed and soil hypothesis revisited-The role of tumor-stroma interactions in metastasis to different organs
- (2011) Robert R. Langley et al. INTERNATIONAL JOURNAL OF CANCER
- Host type I IFN signals are required for antitumor CD8+T cell responses through CD8α+dendritic cells
- (2011) Mercedes B. Fuertes et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Gene expression profiling in acute allograft rejection: challenging the immunologic constant of rejection hypothesis
- (2011) Tara L Spivey et al. Journal of Translational Medicine
- Cancer immunotherapy comes of age
- (2011) Ira Mellman et al. NATURE
- Cancer Immunoediting: Integrating Immunity's Roles in Cancer Suppression and Promotion
- (2011) R. D. Schreiber et al. SCIENCE
- TGF-β and immune cells: an important regulatory axis in the tumor microenvironment and progression
- (2010) Li Yang et al. TRENDS IN IMMUNOLOGY
- Chemokine Expression in Melanoma Metastases Associated with CD8+ T-Cell Recruitment
- (2009) H. Harlin et al. CANCER RESEARCH
- Sunitinib Mediates Reversal of Myeloid-Derived Suppressor Cell Accumulation in Renal Cell Carcinoma Patients
- (2009) J. S. Ko et al. CLINICAL CANCER RESEARCH
- High frequency of tumor-infiltrating FOXP3+regulatory T cells predicts improved survival in mismatch repair-proficient colorectal cancer patients
- (2009) Daniel M. Frey et al. INTERNATIONAL JOURNAL OF CANCER
- Improved Overall Survival With Oxaliplatin, Fluorouracil, and Leucovorin As Adjuvant Treatment in Stage II or III Colon Cancer in the MOSAIC Trial
- (2009) Thierry André et al. JOURNAL OF CLINICAL ONCOLOGY
- In Situ Cytotoxic and Memory T Cells Predict Outcome in Patients With Early-Stage Colorectal Cancer
- (2009) Franck Pagès et al. JOURNAL OF CLINICAL ONCOLOGY
- Cutaneous sebaceous neoplasms as markers of Muir-Torre syndrome: a diagnostic algorithm
- (2009) Ossama Abbas et al. JOURNAL OF CUTANEOUS PATHOLOGY
- Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1
- (2009) David A. Barbie et al. NATURE
- Tumor-Infiltrating FOXP3+ T Regulatory Cells Show Strong Prognostic Significance in Colorectal Cancer
- (2008) Paul Salama et al. JOURNAL OF CLINICAL ONCOLOGY
- The essential role of the in situ immune reaction in human colorectal cancer
- (2008) Franck Pagès et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Cancer-related inflammation
- (2008) Alberto Mantovani et al. NATURE
- Differential Gene Expression Profiles of Metastases in Paired Primary and Metastatic Colorectal Carcinomas
- (2008) Kwi Hye Koh et al. ONCOLOGY
- The immunologic constant of rejection
- (2008) Ena Wang et al. TRENDS IN IMMUNOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More